Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the EsophagusManish A. Shah, Ken Kato, Per Pfeiffer et al.|JAMA Oncology|2018Cited by 518
Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinomaReiko Takayama, Kenji Yamao, Hidewaki Nakagawa et al.|Journal of Gastroenterology|2009Cited by 56
Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: Comparison of failure pattern and toxicities between intensity‐modulated radiotherapy and 3‐dimensional conformal radiotherapyMakoto Ito, Yasuhisa Hasegawa, Takeshi Kodaira et al.|Head & Neck|2017Cited by 32
Genetic architecture of alcohol consumption identified by a genotype-stratified GWAS and impact on esophageal cancer risk in Japanese peopleYuriko N. Koyanagi, Paul Brennan, Masahiro Nakatochi et al.|Science Advances|2024Cited by 27
Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysisSeiichiro Mitani, Kei Muro, Shigenori Kadowaki et al.|Cancer Medicine|2019Cited by 23